|
US2319808A
(en)
|
1939-08-31 |
1943-05-25 |
Squibb & Sons Inc |
Sterol derivatives and process for producing same
|
|
DE2417763A1
(de)
|
1974-04-11 |
1975-10-30 |
Bayer Ag |
Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
|
US4992417A
(en)
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogues
|
|
US4992418A
(en)
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
|
|
JPH01203351A
(ja)
|
1988-02-05 |
1989-08-16 |
Mitsui Petrochem Ind Ltd |
１，４−ジヒドロキシナフタレン誘導体および医薬
|
|
JPH023351A
(ja)
|
1988-06-16 |
1990-01-08 |
Oki Electric Ind Co Ltd |
印刷装置
|
|
US4861891A
(en)
|
1988-08-31 |
1989-08-29 |
Pfizer Inc. |
Antidepressant N-substituted nicotinamide compounds
|
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
|
JPH03184973A
(ja)
|
1989-12-14 |
1991-08-12 |
Rooman Kogyo:Kk |
放射線障害防護剤
|
|
US5260323A
(en)
*
|
1990-06-28 |
1993-11-09 |
Hoechst Aktiengesellschaft |
2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use
|
|
TW197439B
(https=)
|
1991-04-04 |
1993-01-01 |
Ueno Pharmaceutics Applic Res Co Ltd |
|
|
US5283253A
(en)
|
1991-09-23 |
1994-02-01 |
Florida State University |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
|
|
DE4201047A1
(de)
|
1992-01-17 |
1993-07-22 |
Bayer Ag |
Substituierte isoxazolcarbonsaeureamide
|
|
US5272137A
(en)
|
1992-02-14 |
1993-12-21 |
Mcneil-Pfc, Inc. |
Aqueous pharmaceutical suspension for pharmaceutical actives
|
|
US5200534A
(en)
|
1992-03-13 |
1993-04-06 |
University Of Florida |
Process for the preparation of taxol and 10-deacetyltaxol
|
|
US5294637A
(en)
|
1992-07-01 |
1994-03-15 |
Bristol-Myers Squibb Company |
Fluoro taxols
|
|
JP2994182B2
(ja)
|
1992-07-23 |
1999-12-27 |
石原産業株式会社 |
アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
|
|
US5202448A
(en)
|
1992-08-14 |
1993-04-13 |
Napro Biotherapeutics, Inc. |
Processes of converting taxanes into baccatin III
|
|
US5415869A
(en)
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
|
US5474978A
(en)
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
|
US5504188A
(en)
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
|
US5547929A
(en)
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
JP3833281B2
(ja)
*
|
1995-02-03 |
2006-10-11 |
日本曹達株式会社 |
２，６−ジクロロイソニコチン酸ベンジルアミド誘導体及び植物病害防除剤
|
|
YU18596A
(sh)
|
1995-03-31 |
1998-07-10 |
Eli Lilly And Company |
Analogne formulacije monomernog insulina
|
|
DE69631347T2
(de)
*
|
1995-09-15 |
2004-10-07 |
Upjohn Co |
Aminoaryl oxazolidinone n-oxide
|
|
US6072050A
(en)
|
1996-06-11 |
2000-06-06 |
Pioneer Hi-Bred International, Inc. |
Synthetic promoters
|
|
FR2751645B1
(fr)
|
1996-07-29 |
1998-12-24 |
Sanofi Sa |
Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
|
|
AR012894A1
(es)
|
1997-06-13 |
2000-11-22 |
Lilly Co Eli |
Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
|
|
PT1027328E
(pt)
|
1997-10-31 |
2006-11-30 |
Aventis Pharma Ltd |
Anilidas substituídas
|
|
WO1999032444A1
(en)
|
1997-12-22 |
1999-07-01 |
Eli Lilly And Company |
Catalyst and method for amide formation
|
|
DE69906059D1
(de)
|
1998-04-20 |
2003-04-24 |
Fujisawa Pharmaceutical Co |
Anthranilsäurederivate als inhibitoren der c-gmp-phosphodiesterase
|
|
AR019190A1
(es)
*
|
1998-07-08 |
2001-12-26 |
Sod Conseils Rech Applic |
Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
|
|
US6780883B2
(en)
*
|
1998-11-05 |
2004-08-24 |
Warner-Lambert Company |
Amide inhibitors of microsomal triglyceride transfer protein
|
|
ATE276241T1
(de)
|
1998-11-25 |
2004-10-15 |
Yissum Res Dev Co |
Antioxidationsmittel
|
|
GB9919558D0
(en)
|
1999-08-18 |
1999-10-20 |
Hoechst Schering Agrevo Gmbh |
Fungicidal compounds
|
|
WO2001032928A2
(en)
|
1999-11-05 |
2001-05-10 |
Phase-1 Molecular Toxicology |
Methods of determining individual hypersensitivity to an agent
|
|
US20020034783A1
(en)
|
2000-04-18 |
2002-03-21 |
Rachel Meyers |
39228, a novel human alcohol dehydrogenase and uses therefor
|
|
WO2002020500A2
(en)
|
2000-09-01 |
2002-03-14 |
Icos Corporation |
Materials and methods to potentiate cancer treatment
|
|
HK1052011A1
(zh)
*
|
2000-09-15 |
2003-08-29 |
Anormed Inc. |
趋化因子受体结合杂环化合物
|
|
DE60137435D1
(de)
*
|
2000-09-15 |
2009-03-05 |
Anormed Inc |
Chemokin rezeptor bindenden heterozyklische verbindungen
|
|
WO2002053544A1
(en)
|
2000-12-29 |
2002-07-11 |
Darwin Discovery Ltd. |
Pharmaceutical uses and synthesis of nicotinanilide-n-oxides
|
|
DOP2002000332A
(es)
*
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Inhibidores de piridina de metaloproteinasas de la matriz
|
|
US6678516B2
(en)
|
2001-05-21 |
2004-01-13 |
Nokia Corporation |
Method, system, and apparatus for providing services in a privacy enabled mobile and Ubicom environment
|
|
JP4448902B2
(ja)
|
2001-06-08 |
2010-04-14 |
株式会社医薬分子設計研究所 |
スルホンアミド誘導体
|
|
WO2003030937A1
(en)
|
2001-10-05 |
2003-04-17 |
Ono Pharmaceutical Co., Ltd. |
Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
|
|
DE10149674A1
(de)
*
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
US20030100034A1
(en)
*
|
2001-10-16 |
2003-05-29 |
Millennium Pharmaceuticals, Inc. |
9136, a human aldehyde dehydrogenase family member and uses therefor
|
|
PY0300568A
(es)
*
|
2002-01-31 |
2004-10-01 |
Pfizer Prod Inc |
Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi)acetico
|
|
ATE447971T1
(de)
|
2002-02-19 |
2009-11-15 |
Shionogi & Co |
Antipruriginosa
|
|
WO2003086377A1
(en)
|
2002-04-18 |
2003-10-23 |
Institute Of Medicinal Molecular Design. Inc. |
Amide derivatives
|
|
GB0215650D0
(en)
|
2002-07-05 |
2002-08-14 |
Cyclacel Ltd |
Bisarylsufonamide compounds
|
|
CA2497979A1
(en)
|
2002-09-06 |
2004-03-18 |
Elan Pharmaceuticals, Inc. |
1, 3-diamino-2-hydroxypropane prodrug derivatives
|
|
EP1402888A1
(en)
|
2002-09-18 |
2004-03-31 |
Jerini AG |
The use of substituted carbocyclic compounds as rotamases inhibitors
|
|
EP1402887A1
(en)
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
US7022850B2
(en)
|
2003-05-22 |
2006-04-04 |
Bristol-Myers Squibb Co. |
Bicyclicpyrimidones and their use to treat diseases
|
|
JP4359754B2
(ja)
*
|
2003-07-03 |
2009-11-04 |
三菱瓦斯化学株式会社 |
基板の洗浄剤
|
|
EP1649054A1
(en)
|
2003-07-21 |
2006-04-26 |
Oncotherapy Science, Inc. |
Method for diagnosing colorectal cancers
|
|
WO2005011561A2
(en)
|
2003-08-04 |
2005-02-10 |
Labcoat, Ltd. |
Stent coating apparatus and method
|
|
GB0318814D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
|
EP1661572A1
(en)
|
2003-08-18 |
2006-05-31 |
Shionogi & Co., Ltd. |
Novel use of cannabinoid receptor agonist
|
|
FR2861071B1
(fr)
|
2003-10-17 |
2006-01-06 |
Sanofi Synthelabo |
Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
|
|
FR2861074B1
(fr)
|
2003-10-17 |
2006-04-07 |
Sanofi Synthelabo |
Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
|
|
AU2004298048A1
(en)
|
2003-12-09 |
2005-06-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2
|
|
GT200500013A
(es)
*
|
2004-01-23 |
2005-08-10 |
|
Amidas herbicidas
|
|
WO2005084392A2
(en)
|
2004-03-03 |
2005-09-15 |
Convivia |
4-methylpyrazole formulations for inhibiting ethanol intolerance
|
|
WO2005110422A2
(en)
|
2004-05-19 |
2005-11-24 |
Boehringer Ingelheim International Gmbh |
Treatment of diseases associated with altered level of amyloid beta peptides
|
|
CN1749415A
(zh)
|
2004-09-15 |
2006-03-22 |
上海人类基因组研究中心 |
硝酸甘油治疗急性心绞痛疗效检测方法和试剂盒
|
|
ES2377758T3
(es)
*
|
2004-11-12 |
2012-03-30 |
Bristol-Myers Squibb Company |
Compuestos tricíclicos basados en tiazolo[4,5-b]piridina imidazo-fusionada y composiciones farmacéuticas que los comprenden
|
|
US7888374B2
(en)
*
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
|
DOP2006000051A
(es)
|
2005-02-24 |
2006-08-31 |
Lilly Co Eli |
Inhibidores de vegf-r2 y métodos
|
|
HRP20100272T2
(hr)
|
2005-09-23 |
2010-07-31 |
Pfizer Products Incorporated |
Piridinaminosulfonil supstituirani benzamidi kao inhibitori citokroma p450 3a4 (cyp3a4)
|
|
AU2006331765A1
(en)
|
2005-12-22 |
2007-07-05 |
Wyeth |
Substituted isoquinoline-1,3(2H,4H)-diones, 1-thioxo-1,4-dihydro-2H-isoquinoline-3-ones and 1,4-dihydro-3(2H)-isoquinolones and use thereof as kinase inhibitor
|
|
MX2008012404A
(es)
*
|
2006-03-28 |
2008-10-09 |
Novartis Ag |
Derivados de amida y su aplicacion para el tratamiento de enfermedades relacionadas con proteina-g.
|
|
EP2727585A1
(en)
|
2006-05-16 |
2014-05-07 |
Takeda Pharmaceutical Company Limited |
In-vivo screening method
|
|
WO2007136707A2
(en)
|
2006-05-17 |
2007-11-29 |
University Of Utah Research Foundation |
Methods and compositions related to eosinophil regulation
|
|
US20080003585A1
(en)
|
2006-06-29 |
2008-01-03 |
Bio-Rad Laboratories, Inc., A Corporation Of The State Of Delaware |
Purification and amplification of nucleic acids in a microfluidic device
|
|
KR20090033417A
(ko)
|
2006-07-27 |
2009-04-03 |
씨브이 쎄러퓨틱스, 인코포레이티드 |
중독의 치료에서의 ａｌｄｈ-2 저해제
|
|
PE20080906A1
(es)
|
2006-08-17 |
2008-07-05 |
Kemia Inc |
Derivados heteroarilo como inhibidores de citocina
|
|
US8927715B2
(en)
|
2006-08-25 |
2015-01-06 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11β-hydroxysteroid dehydrogenase type 1
|
|
ATE507205T1
(de)
*
|
2006-12-11 |
2011-05-15 |
Genetics Co Inc |
Aromatische 1,4-di-carboxylamide und deren verwendung
|
|
CN101631786A
(zh)
|
2006-12-20 |
2010-01-20 |
先灵公司 |
新颖的jnk抑制剂
|
|
CN101611007A
(zh)
*
|
2006-12-20 |
2009-12-23 |
先灵公司 |
新颖的jnk抑制剂
|
|
WO2008103354A2
(en)
|
2007-02-20 |
2008-08-28 |
Cropsolution, Inc. |
Modulators of acetyl-coenzyme a carboxylase and methods of use thereof
|
|
US20110105602A2
(en)
|
2007-03-08 |
2011-05-05 |
Daria Mochly-Rosen |
Mitochondrial Aldehyde Dehydrogenase-2 Modulators and Methods of Use Thereof
|
|
WO2009086303A2
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
WO2009137045A2
(en)
|
2008-05-07 |
2009-11-12 |
The Board Of Trustees Of The Leland Stanford Junior University |
Crystal structure of aldehyde dehydrogenase and methods of use thereof
|
|
RU2010153656A
(ru)
|
2008-06-04 |
2012-07-20 |
Амбрилиа Байофарма Инк. (Ca) |
Ингибиторы интегразы вич из пиридоксина
|
|
US9187426B2
(en)
*
|
2008-06-27 |
2015-11-17 |
Novartis Ag |
Organic compounds
|
|
US8354435B2
(en)
|
2008-09-08 |
2013-01-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase activity and methods of use thereof
|
|
CN102202669A
(zh)
|
2008-10-28 |
2011-09-28 |
利兰·斯坦福青年大学托管委员会 |
醛脱氢酶调节剂及其使用方法
|
|
CN105254557A
(zh)
|
2009-05-29 |
2016-01-20 |
拉夸里亚创药株式会社 |
作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
|
|
JP5947307B2
(ja)
|
2010-10-20 |
2016-07-06 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
Ｋｃｎｑ２／３調節因子としての置換６−アミノ−ニコチンアミド
|
|
US20140088187A1
(en)
|
2010-12-14 |
2014-03-27 |
Beth Israel Deaconess Medical Center |
Androgen receptor inhibitors and methods of use thereof
|
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
|
MX2014002542A
(es)
|
2011-08-29 |
2014-07-09 |
Infinity Pharmaceuticals Inc |
Compuestos heterociclicos y usos de los mismos.
|